A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
In September, David Baltimore — the scientist who discovered reverse transcriptase, a breakthrough often described as one of ...
Avatar: Fire & Ash stars Sam Worthington and Stephen Lang talked to us about how their characters have changed throughout the ...
YouTube on MSN
COVID Variant Recombination: Threat or Achilles Heel?
This episode is brought to you by the “Things You Don’t Need to Know” podcast. This show will teach you about things you wouldn’t normally learn. Scientists may have found a recombinant variant of ...
Discover the essential role of TGF-Beta 1 in cellular regulation, its signaling pathway, and how TGF-β1 antibodies are used ...
The vaccine developers market shows significant opportunities through increased demand, collaborative partnerships, and ...
Australian animal-free casein maker Eden Brew has filed the country's first regulatory application for a precision-fermented ...
On Oct. 31, 2025, the Ninth Circuit issued an opinion that will likely drive substantial changes to federal regulations governing label disclosures ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback